N.J., July 28, 2026 /PRNewswire/ — Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch1 of Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Doserapeutically equivalent to the reference listed drug, BRIDION®2 Injection, 100 mg/mL of Merck Sharp & Dohme LLC [NDA 022225]
ABS TV and ABS Network News is a leading Pan-African 24/7 broadcasting network delivering nonstop news, talk shows, lifestyle programs, and digital media content worldwide through Satellite, Streaming Platforms, and Roku TV.
Based in the United States, we connect Africa to the world while empowering creators, journalists, and brands through innovative media and broadcasting services.
© 2026 Copyright. All Rights Reserved by ABSAFRICATV